Defective signal-transduction pathways in T-cells from autoimmune MRL-lpr/lpr mice are associated with increased polyamine concentrations

Biochem J. 1995 Oct 1;311 ( Pt 1)(Pt 1):175-82. doi: 10.1042/bj3110175.

Abstract

We previously reported that difluoromethylornithine (DFMO), an inhibitor of polyamine biosynthesis, exerted significant beneficial effects on the lifespan and disease expression of MRL-lpr/lpr mice, which spontaneously develop a lupus-like syndrome. Polyamine levels in splenic T-cells of MRL-lpr/lpr mice were significantly higher than those of Balb/c mice. In the present investigation, we examined the role of endogenous polyamines in transmembrane Ca2+ influx, generation of InsP3 and tyrosine phosphorylation of the p56lck protein in concanavalin A-stimulated splenic T-cells. Cytosolic free calcium concentrations ([Ca2+]i) in concanavalin A-stimulated T-cells of MRL-lpr/lpr and Balb/c mice were 250 +/- 25 and 450 +/- 42 nM respectively. Treatment of MRL-lpr/lpr mice with DFMO increased [Ca2+]i to 360 +/- 30 nM (P < 0.05). InsP3 levels of concanavalin A-stimulated MRL-lpr/lpr splenic T-cells were only 20% higher than those of unstimulated controls, whereas those of Balb/c T-cells were 90% higher. DFMO treatment increased InsP3 levels in concanavalin A-treated MRL-lpr/lpr T-cells to 67%. Western-blot analysis showed a 7-fold higher level of p56lck phosphorylation of MRL-lpr/lpr splenic T-cells than that of Balb/c mice. DFMO treatment reduced tyrosine phosphorylation of p56lck of MRL-lpr/lpr mice significantly (P < 0.001). Two-colour flow-cytometric analysis revealed no significant difference in the CD4+/CD8+ ratio in splenic T-cells of MRL-lpr/lpr mice after DFMO treatment. Polyamine levels in splenocytes were significantly reduced by DFMO treatment. These data show that DFMO treatment could alter signal-transduction pathways of splenic T-cells of MRL-lpr/lpr mice. Increased levels of polyamines in T-cells of untreated lpr mice contribute to defective signal-transduction pathways and the pathogenesis of lupus-like symptoms.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Autoimmune Diseases / physiopathology*
  • Blotting, Western
  • CD4-CD8 Ratio
  • Calcium / metabolism
  • Concanavalin A / pharmacology
  • Eflornithine / pharmacology
  • Female
  • Inositol Phosphates / metabolism
  • Lupus Erythematosus, Systemic / physiopathology
  • Mice
  • Mice, Inbred BALB C
  • Ornithine Decarboxylase / metabolism
  • Phosphorylation
  • Phosphotyrosine / metabolism
  • Polyamines / antagonists & inhibitors
  • Polyamines / metabolism
  • Signal Transduction*
  • Spleen / cytology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / pathology
  • T-Lymphocytes / physiology*

Substances

  • Inositol Phosphates
  • Polyamines
  • Concanavalin A
  • Phosphotyrosine
  • Ornithine Decarboxylase
  • Calcium
  • Eflornithine